In today's trading, investors are looking to extend their gains to three days, tying all the way back to last week's jobs numbers. Today's upswing is powered by earnings beats and the return of monetary policy rumors. Every time the Federal Reserve and European Central Bank exit a policy meeting without committing to any action, talk of market-boosting intervention vanishes for a couple of days... until everyone remembers the global economy still stinks and policymakers would be negligent to sit on their hands, and the rumor mill starts up again.
Let's take a closer look at how the three major indexes are faring and check out several stocks making headlines.
Index |
Gain/Loss |
Gain/Loss % |
Intraday Value |
---|---|---|---|
Dow Jones Industrial Average |
66.48 | 0.51% | 13,162.65 |
Nasdaq | 19.75 | 0.67% | 2,987.65 |
S&P 500 | 6.54 | 0.47% | 1,397.53 |
Source: Yahoo! Finance as of 10:45 a.m. EDT.
About 80% of the Dow's components are seeing green, with the biggest gainer being JPMorgan Chase
The biggest headline among Dow components is arguably a clinical trial failure for Johnson & Johnson and Pfizer
Speculative stocks hold the allure of substantial short-term gains, and drug approvals are often a key catalyst. But there are arguably better and more stable approaches to building long-term wealth and retiring well. In our free report, "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you, as well as some winning wealth-building strategies. Click here to keep reading.